Analytical Testing

Pharmaceutical Outsourcing Analytical Testing - Laptop Showing Data

Analytical testing services outsourcing allows pharmaceutical innovator companies to handle more complex tasks in-house while also assisting companies in concentrating on their core competencies, enabling pharmaceutical companies to avoid developing specialized facilities and hiring staff, results in cost savings.

Specifically, pharmaceutical analytical testing refers to quantifying and identifying components in pharmaceutical drugs and solutions. The goal is to ensure products meet FDA regulations for safety, potency, purity, and stability.

Analytical development and testing services may also include method development, method transfers, qualification and validation services.

Filter

Hide Filter

Tactical Versus Strategic Outsourcing: Are the Drivers the Same for Large, Medium, and Small Sponsor Companies?
Monday, March 26, 2012
In any venue where clinical development outsourcing is being discussed, sooner or later someone always seems to wonder aloud if small companies can get the same attention from their providers that large companies do. What’s intriguing about this ... read more
Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer
Thursday, March 15, 2012
Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ... read more
Using Advanced Drug Development Technologies For Better Treatments
Thursday, March 15, 2012
Somerset, NJ – March 15, 2012 – Catalent Pharma Solutions, a leading global industry partner in product development, delivery and supply has extensive expertise in bringing more products to more markets around the world and will present a series of ... read more
INC Research to Discuss Global Partnerships and Future Trends
Tuesday, February 28, 2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the evolution of clinical development outsourcing trends at the Partnerships(TM) in Clinical ... read more
ICON Acquires PriceSpective
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ... read more
Boehringer Ingelheim and Xencor Enter a Collaboration Agreement
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ... read more
Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the... read more
Ockham Completes Acquisition of Nexus Oncology
Thursday, February 16, 2012
Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announces it has completed the acquisition of Nexus Oncology. The transaction also provides Ockham with an institutional investment partner. read more
One Year On…Almac Doubles Analytical Capacity in US Headquarters
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ... read more
INC Research Releases New White Paper
Wednesday, February 08, 2012
INC Research , LLC, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, today announced it has released a new white paper titled, "The Innovation Imperative: How CROs Are Driving The... read more
Global Outsourcing
Sunday, January 01, 2012
Global outsourcing of pre-clinical studies is an increasingly important aspect of drug discovery and development. In order to extract the most value out of an outsourced pre-clinical project abroad there are several strategic decisions that require ... read more
Analytical Testing Roundtable
Sunday, January 01, 2012
DN: In my experience, the single most significant trend in pharmaceutical outsourcing in general, and analytical testing in particular, is the emergence of so-called “preferred vendors”. In the early 1990s there were only a few contract research ... read more
Forced Degradation to Develop Stability-indicating Methods
Sunday, January 01, 2012
Forced Degradation (or stress testing) typically involves exposure of drug substances to heat, heat and humidity and light for solid-state studies. For solution-state studies the drug substance is exposed to a range of pH values. The experimental ... read more
Relationships with External Partners in Compound Management
Sunday, January 01, 2012
This paper outlines how pharmaceutical companies best use external resources to support compound management activities while their internal resources focus on core responsibilities. It also elaborates on compound management workflows in support of ... read more
Quintiles Completes Acquisition of Advion BioServices
Monday, November 07, 2011
Quintiles’ ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier ... read more